Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
Thomas Pincez: Emerging Challenges in Sickle Cell Disease Gene Therapy and Cancer Risk
Thomas Pincez/LinkedIn
May 24, 2026, 13:10

Thomas Pincez: Emerging Challenges in Sickle Cell Disease Gene Therapy and Cancer Risk

Thomas Pincez, Adjunct Professor at McGill University, Assistant Professor at University of Montreal, Clinician-Scientist at Azrieli Research Centre of CHU Sainte-Justine, shared a post on LinkedIn about recent articles he and his colleagues co-authored, adding:

“Two reviews on current sickle cell disease challenges: Gene therapy and Cancer risk.

Thanks for this great work within RED.”

Title: The Journey of Gene Therapy in Sickle Cell Disease: How Molecular Advances Meet Clinical Care

Authors: Magalie Tardif, Manon Saby, Stéphanie Forté, Thomas Pincez

Read the Full Article on Cells.

Thomas Pincez: Emerging Challenges in Sickle Cell Disease Gene Therapy and Cancer Risk

Title: Should Sickle Cell Disease Be Considered a Cancer Predisposition Syndrome?

Authors: Elise Casadessus, Yves Pastore, Thomas Pincez

Read the Full Article on Children.

Thomas Pincez: Emerging Challenges in Sickle Cell Disease Gene Therapy and Cancer Risk

Stay updated on all scientific advances with Hemostasis Today.

Elise Casadessus Health Hematology Hemostasis Hemostasis News Hemostasis Today Magalie Tardif Manon Saby Stéphanie Forté Thomas Pincez Yves Pastore
NewsFeed